Tag : Immediate

CCT Impact

Khiron Medical Cannabis Products Arrive in Germany for Immediate Prescription, Sale and Distribution

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that the Company has successfully delivered EU-GMP medical cannabis product to Germany. In collaboration with Nimbus Health, a leading medical cannabis distributor in Germany, Khiron......
CCT Impact

Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets

CCT IMPACT Agent
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab“), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is thrilled to announce the Canadian Intellectual Property Office (“CIPO“) has allowed Canadian Patent No. CA 3050150 to Canntab, related to its proprietary cannabidiol......